Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A

Neuromuscular Disorders

Volumn 23, Issue 11, 2013, Pages 902-906

  Ursino, Giulia ^a   Alberti, M Antonia ^b   Grandis, Marina ^a   Reni, Lizia ^a   Pareyson, Davide ^c   Bellone, Emilia ^a   Gemelli, Chiara ^a   Sabatelli, Mario ^d   Pisciotta, Chiara ^e   Luigetti, Marco ^d   Santoro, Lucio ^e   Massollo, Laura ^a   Schenone, Angelo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c IRCCS MULTIMEDICA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

CMT; CMT1A; Diabetes; Hypothyroidism; Obesity; Phenotype; Toxic

Indexed keywords

INSULIN; LEAD; ORAL ANTIDIABETIC AGENT; PESTICIDE; TAR; THYROID HORMONE; VINCRISTINE;

ADULT; ARTICLE; CHARCOT MARIE TOOTH NEUROPATHY SCORE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISABILITY; DISEASE EXACERBATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HODGKIN DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MOTOR NERVE CONDUCTION; MOTOR UNIT POTENTIAL; NEUROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM;

CMT; CMT1A; DIABETES; HYPOTHYROIDISM; OBESITY; PHENOTYPE; TOXIC;

CHARCOT-MARIE-TOOTH DISEASE; COMORBIDITY; DIABETES COMPLICATIONS; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; NEUROTOXINS; OBESITY; RETROSPECTIVE STUDIES;

EID: 84884978102     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2013.07.002     Document Type: Article

References (24)

1. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974, 6:98-118.
2. Nelis E., Van Broeckhoven C., De Jonghe P., et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 1996, 4:25-33.
3. Lupski J.R., de Oca-Luna R.M., Slaugenhaupt S., et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991, 66:219-232.
4. Patel P.I., Roa B.B., Welcher A.A., et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992, 1:159-165.
5. Harding A.E., Thomas P.K. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980, 103:259-280.
6. Birouk N., Gouider R., Le Guern E., et al. Charcot-Marie-Tooth disease type A with 17p11-2 duplication. Clinical and electrophysiological phenotype study factors influencing disease severity in 119 cases. Brain 1997, 120:813-823.
7. Thomas P.K., Marques W., Davis M.B., et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997, 120:465-478.
8. Takahura Y., Furuya H., Yamashita K., et al. A case of Charcot-Marie-Tooth disease (CMT) type 1 complicated by diabetes mellitus showing bilateral phrenic nerve palsy. Rinsho Shinkeigaku 2002, 42:320-322.
9. Parks N.E., Benstead J.T. Charcot ankle artropahty in CMT1A exacerbated by type 2 diabetes mellitus. Can J Neurol 2010, 37:419-421.
10. Win H.H., Davenport C., Delaney S., Kelly M., Smith D. Charcot-Marie-Tooth disease complicating type 2 diabetes. J Am Podiatr Med Assoc 2011, 101:349-352.
11. Celik M., Forta H., Parman Y., Bissar-Tadmouri N., Demirkirkan K., Battaloglu E. Charcot-Marie-Tooth disease associated with type 2 diabetes mellitas. Diabet Med 2001, 18:685-686.
12. Koç F., Sarica Y., Yerdelen D. A large family with Charcot-Marie-Tooth type 1A and type 2 diabetes mellitus. Intern J Neuroscience 2006, 116:103-114.
13. Sheth S., Francies K., Siskind C.E., et al. Diabetes mellitus exacerbates motor and sensory impairment in CMT1A. J Peripher Nerv Syst 2008, 13:299-304.
14. Llewelyn J.G., Tomlinson D.R., Thomas P.K. Diabetic neuropathies. Peripheral neuropathy 2005, 1951-1991. Elsevier Saunders, Philadelphia. P.J. Dyck, P.K. Thomas (Eds.).
15. Nemni R., Bottacchi E., Fazio R., et al. Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases. J Neurol Neurosurg Psychiatry 1987, 50:1454-1460.
16. Duyff R.F., Van Den Bosch J., Laman D.M., Van Loon B.J., Linssen W.H. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry 2000, 68:750-755.
17. Weimer L.H., Podwall D. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease. J Neurol Sci 2006, 242:47-54.
18. Shy M.E., Blake J., Krajewski K., et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005, 64:1209-1214.
19. Krajewski K.M., Lewis R.A., Fuerst D.R., et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000, 123:1516-1527.
20. Maser R.E., Steenkiste A.R., Dorman J.S., et al. Epidemiological correlates of diabetic neuropathy. Report from pittsburgh epidemiology of diabetes complications study. Diabetes 1989, 38:1456-1461.
21. Rao S.N., Katiyar B.C., Nair K.R.P., et al. Neuromuscular status in hypothyroidism. Acta Neurol Scand 1980, 61:167-177.
22. Dyck P.J., Lambert E.H. Polyneuropathy associated with hypotiroidism. J Neuropatol Exp Neurol 1970, 29:631-658.
23. Sidenius P., Nagel P., Larsen J.R., Boye N., Laurberg P. Axonal transport velocity of slow component in a sciatic nerves of hypo and hyperthyroid rats. J Neurochem 1987, 49:1790-1795.
24. Madorsky I., Opalach K., Waber A., et al. Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease. Neurobiol Dis 2009, 34:146-154.